Evolving perspectives in reverse cardio-oncology: A review of current status, pathophysiological insights, and future directives

Cardiovascular disease (CVD) and cancer are leading causes of mortality worldwide, traditionally linked through adverse effects of cancer therapies on cardiovascular health. However, reverse cardio-oncology, a burgeoning field, shifts this perspective to examine how cardiovascular diseases influence...

Full description

Saved in:
Bibliographic Details
Published in:Current problems in cardiology 2024-03, Vol.49 (3), p.102389-102389, Article 102389
Main Authors: Imran, Shahzeb, Rao, Medha Sridhar, Shah, Muhammad Hamza, Gaur, Aditya, Guernaoui, Abderrahmane El, Roy, Subham, Roy, Sakshi, Bharadwaj, Hareesha Rishab, Awuah, Wireko Andrew
Format: Article
Language:English
Subjects:
Cardio-Oncology
Cardiovascular Diseases - etiology
Cardiovascular Diseases - therapy
Humans
Inflammation
Neoplasms - therapy
Risk Factors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cardiovascular disease (CVD) and cancer are leading causes of mortality worldwide, traditionally linked through adverse effects of cancer therapies on cardiovascular health. However, reverse cardio-oncology, a burgeoning field, shifts this perspective to examine how cardiovascular diseases influence the onset and progression of cancer. This novel approach has revealed a higher likelihood of cancer development in patients with pre-existing cardiovascular conditions, attributed to shared risk factors such as obesity, a sedentary lifestyle, and smoking. Underlying mechanisms like chronic inflammation and clonal hematopoiesis further illuminate the connections between cardiovascular ailments and cancer. This comprehensive narrative review, spanning a broad spectrum of studies, outlines the syndromic classification of cardio-oncology, the intersection of cardiovascular risk factors and oncogenesis, and the bidirectional dynamics between CVD and cancer. Additionally, the review also discusses the pathophysiological mechanisms underpinning this interconnection, examining the roles of cardiokines, genetic factors, and the effects of cardiovascular therapies and biomarkers in cancer diagnostics. Lastly, it aims to underline future directives, emphasising the need for integrated healthcare strategies, interdisciplinary research, and comprehensive treatment protocols.
ISSN:0146-2806
1535-6280
DOI:10.1016/j.cpcardiol.2024.102389